ES2821407T8 - Compuestos de piperidina sustituidos con indol como agentes degradantes de los receptores de estrógenos - Google Patents
Compuestos de piperidina sustituidos con indol como agentes degradantes de los receptores de estrógenosInfo
- Publication number
- ES2821407T8 ES2821407T8 ES17769483T ES17769483T ES2821407T8 ES 2821407 T8 ES2821407 T8 ES 2821407T8 ES 17769483 T ES17769483 T ES 17769483T ES 17769483 T ES17769483 T ES 17769483T ES 2821407 T8 ES2821407 T8 ES 2821407T8
- Authority
- ES
- Spain
- Prior art keywords
- estrogen receptor
- piperidine compounds
- substituted piperidine
- degrading agents
- indole substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610180518 | 2016-03-25 | ||
| CN201610867918 | 2016-09-29 | ||
| PCT/CN2017/078139 WO2017162206A1 (zh) | 2016-03-25 | 2017-03-24 | 作为雌激素受体降解剂的吲哚并取代哌啶类化合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES2821407T3 ES2821407T3 (es) | 2021-04-26 |
| ES2821407T8 true ES2821407T8 (es) | 2022-02-02 |
Family
ID=59899253
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES17769483T Active ES2821407T3 (es) | 2016-03-25 | 2017-03-24 | Compuestos de piperidina sustituidos con indol como agentes degradantes de los receptores de estrógenos |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US10519143B2 (es) |
| EP (1) | EP3434668B1 (es) |
| JP (1) | JP6790222B2 (es) |
| KR (1) | KR102111792B1 (es) |
| CN (1) | CN108884035B (es) |
| AU (1) | AU2017239348B2 (es) |
| CA (1) | CA3018801C (es) |
| ES (1) | ES2821407T3 (es) |
| HK (1) | HK1256936A1 (es) |
| RU (1) | RU2722441C2 (es) |
| SG (1) | SG11201808363TA (es) |
| WO (1) | WO2017162206A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019057201A1 (zh) * | 2017-09-25 | 2019-03-28 | 罗欣生物科技（上海）有限公司 | 一种雌激素受体抑制剂的晶型及其制备方法 |
| AU2019321588A1 (en) | 2018-08-17 | 2021-03-04 | Genentech, Inc. | Diagnostic and therapeutic methods for the treatment of breast cancer |
| JP7416540B2 (ja) * | 2018-11-28 | 2024-01-17 | 羅欣薬業（上海）有限公司 | エストロゲン受容体ダウンレギュレーターの塩形態、結晶形及びその製造方法 |
| KR20210105384A (ko) * | 2018-12-17 | 2021-08-26 | 치아타이 티안큉 파마수티컬 그룹 주식회사 | 에스트로겐 수용체 길항제 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW397821B (en) * | 1996-04-19 | 2000-07-11 | American Home Produits Corp | 3-[4-(2-phenyl-indole-1-ylmethyl)-phenyl]-acrylamides and 2-phenyl-1-[4-(amino-1-yl-alk-1-ynyl)-benzyl]-1H-indol-5-ol as well as pharmaceutical compositions of estrogenic agents thereof |
| US20100317635A1 (en) * | 2009-06-16 | 2010-12-16 | Endorecherche, Inc. | Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators |
| GB0917571D0 (en) * | 2009-10-07 | 2009-11-25 | Karobio Ab | Novel estrogen receptor ligands |
| GB2483736B (en) * | 2010-09-16 | 2012-08-29 | Aragon Pharmaceuticals Inc | Estrogen receptor modulators and uses thereof |
| NZ630124A (en) | 2012-03-20 | 2016-01-29 | Seragon Pharmaceuticals Inc | Estrogen receptor modulators and uses thereof |
| AU2015228860A1 (en) * | 2014-03-13 | 2016-09-08 | F. Hoffmann-La Roche Ag | Methods and compositions for modulating estrogen receptor mutants |
| EP3116497A2 (en) | 2014-03-13 | 2017-01-18 | F. Hoffmann-La Roche AG | Therapeutic combinations with estrogen receptor modulators |
-
2017
- 2017-03-24 CA CA3018801A patent/CA3018801C/en active Active
- 2017-03-24 KR KR1020187030877A patent/KR102111792B1/ko active IP Right Grant
- 2017-03-24 RU RU2018135203A patent/RU2722441C2/ru active
- 2017-03-24 CN CN201780019970.8A patent/CN108884035B/zh active Active
- 2017-03-24 US US16/087,861 patent/US10519143B2/en active Active
- 2017-03-24 ES ES17769483T patent/ES2821407T3/es active Active
- 2017-03-24 SG SG11201808363TA patent/SG11201808363TA/en unknown
- 2017-03-24 WO PCT/CN2017/078139 patent/WO2017162206A1/zh active Application Filing
- 2017-03-24 JP JP2019500726A patent/JP6790222B2/ja active Active
- 2017-03-24 EP EP17769483.3A patent/EP3434668B1/en active Active
- 2017-03-24 AU AU2017239348A patent/AU2017239348B2/en active Active
-
2018
- 2018-12-13 HK HK18116063.8A patent/HK1256936A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2017239348B2 (en) | 2020-03-12 |
| KR20180128456A (ko) | 2018-12-03 |
| JP6790222B2 (ja) | 2020-11-25 |
| CN108884035B (zh) | 2020-03-13 |
| EP3434668A4 (en) | 2019-08-14 |
| ES2821407T3 (es) | 2021-04-26 |
| JP2019512550A (ja) | 2019-05-16 |
| SG11201808363TA (en) | 2018-10-30 |
| RU2018135203A3 (es) | 2020-04-27 |
| CA3018801A1 (en) | 2017-09-28 |
| WO2017162206A1 (zh) | 2017-09-28 |
| CA3018801C (en) | 2020-06-23 |
| CN108884035A (zh) | 2018-11-23 |
| KR102111792B1 (ko) | 2020-05-18 |
| HK1256936A1 (zh) | 2019-10-04 |
| EP3434668B1 (en) | 2020-08-26 |
| US10519143B2 (en) | 2019-12-31 |
| AU2017239348A1 (en) | 2018-11-15 |
| RU2018135203A (ru) | 2020-04-27 |
| EP3434668A1 (en) | 2019-01-30 |
| US20190106414A1 (en) | 2019-04-11 |
| RU2722441C2 (ru) | 2020-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA46188A (fr) | Composés indole substitués par pyridyle | |
| EP3512842A4 (en) | INDOLDER DERIVATIVES AS A DEGRADOR OF THE ESTROGEN RECEPTOR | |
| IL275356A (en) | Modified indole compounds for use as TLR inhibitors | |
| IL261947A (en) | History of converted indole compounds as inhibitors of dengue virus replication | |
| IL261948B (en) | Transduced indulin derivatives as inhibitors of dengue virus replication | |
| ES2643164T3 (es) | Indol 7-sustituido como inhibidores de Mcl-1 | |
| DK3313838T3 (da) | Polycykliske amidderivater som cdk9-inhibitorer | |
| ES2930298T3 (es) | Moduladores del receptor de glucocorticoides de azadecalina condensada con heteroaril-cetona | |
| DK3820873T3 (da) | Selektive østrogenreceptornedbrydere | |
| RS62598B1 (sr) | N-supstituisani derivati indola kao modulatori receptora pge2 | |
| IL275342A (en) | Converted indole ether compounds | |
| ES2821407T8 (es) | Compuestos de piperidina sustituidos con indol como agentes degradantes de los receptores de estrógenos | |
| DK3798217T3 (da) | Piperidin-cxcr7-receptormodulatorer | |
| DK3212637T3 (da) | Dopamin-d3-receptorantagonistforbindelser | |
| CL2016002240A1 (es) | Derivados de piperidina como antagonista de receptores de orexina | |
| DK3820874T3 (da) | Selektive estrogenreceptornedbrydere | |
| DK3265459T3 (da) | Amidforbindelser som 5-ht4-receptoragonister | |
| DK3145916T3 (da) | Imidazolderivater som formylpeptidreceptormodulatorer | |
| BRPI1008855A2 (pt) | derivados de indol como agentes anticâncer | |
| SG11201700655WA (en) | Piperazine derivatives as liver x receptor modulators | |
| ZA201804966B (en) | 2-oxindole compounds | |
| HUP1800250A2 (en) | Substituted (aza)indole derivatives | |
| BRPI1011522A2 (pt) | compostos de indol substituídos como moduladores receptor de bradiquinina 1. | |
| HK1243705A1 (zh) | 吲哚衍生物 | |
| DK3497075T3 (da) | Fremgangsmåde til fremstilling af substituerede styren-derivater |